S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
5 Trends You Need to Know This Quarter
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
5 Trends You Need to Know This Quarter
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
5 Trends You Need to Know This Quarter
The US and UK restrict the trade of Russian-origin metals
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Closing prices for crude oil, gold and other commodities
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
How major US stock indexes fared Friday, 4/12/2024
MarketBeat Week in Review – 4/8 - 4/12
Faced with possibly paying for news, Google removes links to California news sites for some users
5 Trends You Need to Know This Quarter
The US and UK restrict the trade of Russian-origin metals

Aligos Therapeutics (ALGS) Short Interest Ratio & Short Volume

$1.00
-0.06 (-5.66%)
(As of 04/12/2024 ET)

Aligos Therapeutics Short Interest Data

Current Short Volume
868,800 shares
Previous Short Volume
365,600 shares
Change Vs. Previous Month
+137.64%
Dollar Volume Sold Short
$851,424.00
Short Interest Ratio / Days to Cover
2.3
Last Record Date
March 31, 2024
Outstanding Shares
75,670,000 shares
Percentage of Shares Shorted
1.15%
Today's Trading Volume
294,101 shares
Average Trading Volume
379,156 shares
Today's Volume Vs. Average
78%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Aligos Therapeutics ?

Sign up to receive the latest short interest report for Aligos Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALGS Short Interest Over Time

ALGS Days to Cover Over Time

ALGS Percentage of Float Shorted Over Time

Aligos Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024868,800 shares $851,424.00 +137.6%N/A2.3 $0.98
3/15/2024365,600 shares $336,900.40 -1.0%N/A0.9 $0.92
2/29/2024369,100 shares $365,409.00 +16.4%N/A0.8 $0.99
2/15/2024317,100 shares $203,578.20 -64.6%N/A0.8 $0.64
1/31/2024894,500 shares $617,205.00 +6.4%N/A3 $0.69
1/15/2024840,400 shares $619,458.84 -1.7%N/A2.8 $0.74
12/31/2023855,200 shares $567,852.80 -1.1%N/A3.1 $0.66
12/15/2023864,400 shares $505,760.44 +14.2%N/A4.1 $0.59
11/30/2023756,900 shares $529,830.00 +4.4%2.4%4.6 $0.70
11/15/2023724,800 shares $456,624.00 -1.3%2.3%9.2 $0.63
10/31/2023734,600 shares $440,760.00 -3.4%4.1%10.1 $0.60
10/15/2023760,700 shares $562,918.00 +1.0%2.8%10.8 $0.74
9/30/2023753,300 shares $562,715.10 -1.6%2.8%10.7 $0.75
9/15/2023765,200 shares $612,160.00 +0.6%2.9%10.1 $0.80
8/31/2023761,000 shares $655,221.00 +2.6%2.9%7.7 $0.86
8/15/2023742,100 shares $693,863.50 -4.5%2.8%6.9 $0.94
7/31/2023776,800 shares $691,352.00 -3.3%2.8%3.5 $0.89
7/15/2023803,500 shares $827,605.00 -1.7%2.9%3.8 $1.03
6/30/2023817,600 shares $793,889.60 +4.1%3.0%3.9 $0.97
6/15/2023785,700 shares $864,270.00 -14.3%2.9%3.7 $1.10
5/31/2023917,000 shares $1.04 million +25.0%3.4%4.5 $1.13
5/15/2023733,500 shares $953,550.00 -5.3%2.7%3.6 $1.30
4/30/2023774,500 shares $898,420.00 -0.3%2.8%7.7 $1.16
4/15/2023776,800 shares $722,346.32 -6.8%2.8%5.8 $0.93
3/31/2023833,000 shares $728,042.00 -4.4%3.0%2.8 $0.87
3/15/2023871,200 shares $1.17 million +2.0%3.3%2.2 $1.34
2/28/2023853,900 shares $1.25 million +16.2%2.9%2.1 $1.46
2/15/2023735,100 shares $1.19 million +0.7%2.5%1.8 $1.62
1/31/2023730,300 shares $1.42 million +128.4%2.7%1.8 $1.94
1/15/2023319,800 shares $524,472.00 -17.6%1.2%0.9 $1.64
12/30/2022387,900 shares $369,629.91 -3.5%1.4%1.8 $0.95
12/15/2022402,100 shares $381,995.00 +3.2%1.5%4.6 $0.95
11/30/2022389,500 shares $389,500.00 -7.1%1.4%5.2 $1.00
11/15/2022419,300 shares $427,686.00 +17.6%1.5%5.7 $1.02
10/31/2022356,700 shares $374,535.00 +1.1%1.6%4.8 $1.05
10/15/2022353,000 shares $388,300.00 +4.6%1.6%4.5 $1.10
9/30/2022337,600 shares $371,360.00 -13.5%1.5%3.4 $1.10
9/15/2022390,300 shares $519,099.00 +11.7%1.7%2.6 $1.33
8/31/2022349,300 shares $436,625.00 -20.2%1.6%2.1 $1.25
8/15/2022437,800 shares $682,968.00 -13.3%2.0%2.1 $1.56
SHOCKING Altcoin Moves… (Ad)

Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…

Click here to register now

ALGS Short Interest - Frequently Asked Questions

What is Aligos Therapeutics' current short interest?

Short interest is the volume of Aligos Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 868,800 shares of ALGS short. Learn More on Aligos Therapeutics' current short interest.

What is a good short interest ratio for Aligos Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALGS shares currently have a short interest ratio of 2.0. Learn More on Aligos Therapeutics's short interest ratio.

Which institutional investors are shorting Aligos Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aligos Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Aligos Therapeutics' short interest increasing or decreasing?

Aligos Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 868,800 shares, an increase of 137.6% from the previous total of 365,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Aligos Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Aligos Therapeutics: Cidara Therapeutics, Inc. (0.22%), Cognition Therapeutics, Inc. (0.53%), Turnstone Biologics Corp. (4.74%), Assembly Biosciences, Inc. (1.17%), AlloVir, Inc. (5.48%), Passage Bio, Inc. (3.57%), Semper Paratus Acquisition Co. (0.25%), Atara Biotherapeutics, Inc. (9.41%), Instil Bio, Inc. (0.22%), Elutia Inc. (0.14%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Aligos Therapeutics stock?

Short selling ALGS is an investing strategy that aims to generate trading profit from Aligos Therapeutics as its price is falling. ALGS shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aligos Therapeutics?

A short squeeze for Aligos Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALGS, which in turn drives the price of the stock up even further.

How often is Aligos Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALGS, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ALGS) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners